174 related articles for article (PubMed ID: 32626975)
41. Effect of Hypoxia in the Transcriptomic Profile of Lung Fibroblasts from Idiopathic Pulmonary Fibrosis.
Romero Y; Balderas-Martínez YI; Vargas-Morales MA; Castillejos-López M; Vázquez-Pérez JA; Calyeca J; Torres-Espíndola LM; Patiño N; Camarena A; Carlos-Reyes Á; Flores-Soto E; León-Reyes G; Sierra-Vargas MP; Herrera I; Luis-García ER; Ruiz V; Velázquez-Cruz R; Aquino-Gálvez A
Cells; 2022 Sep; 11(19):. PubMed ID: 36230977
[TBL] [Abstract][Full Text] [Related]
42. The Role of KCNMB1 and BK Channels in Myofibroblast Differentiation and Pulmonary Fibrosis.
Scruggs AM; Grabauskas G; Huang SK
Am J Respir Cell Mol Biol; 2020 Feb; 62(2):191-203. PubMed ID: 31486669
[TBL] [Abstract][Full Text] [Related]
43. STAT-3 contributes to pulmonary fibrosis through epithelial injury and fibroblast-myofibroblast differentiation.
Pedroza M; Le TT; Lewis K; Karmouty-Quintana H; To S; George AT; Blackburn MR; Tweardy DJ; Agarwal SK
FASEB J; 2016 Jan; 30(1):129-40. PubMed ID: 26324850
[TBL] [Abstract][Full Text] [Related]
44. Expression of fibroblast growth factor 9 in normal human lung and idiopathic pulmonary fibrosis.
Coffey E; Newman DR; Sannes PL
J Histochem Cytochem; 2013 Sep; 61(9):671-9. PubMed ID: 23797050
[TBL] [Abstract][Full Text] [Related]
45. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
46. Lung myofibroblast transition and fibrosis is regulated by circ0044226.
Zhang L; Chi X; Luo W; Yu S; Zhang J; Guo Y; Ren Q; Zhang W
Int J Biochem Cell Biol; 2020 Jan; 118():105660. PubMed ID: 31786325
[TBL] [Abstract][Full Text] [Related]
47. Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis.
Bellaye PS; Shimbori C; Yanagihara T; Carlson DA; Hughes P; Upagupta C; Sato S; Wheildon N; Haystead T; Ask K; Kolb M
Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29386344
[TBL] [Abstract][Full Text] [Related]
48. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.
Bouros E; Filidou E; Arvanitidis K; Mikroulis D; Steiropoulos P; Bamias G; Bouros D; Kolios G
Pulm Pharmacol Ther; 2017 Oct; 46():78-87. PubMed ID: 28865842
[TBL] [Abstract][Full Text] [Related]
49. Vascular dysfunction by myofibroblast activation in patients with idiopathic pulmonary fibrosis and prognostic significance.
Parra ER; Falzoni R; Capelozzi VL
Braz J Med Biol Res; 2012 Jul; 45(7):665-75. PubMed ID: 22527129
[TBL] [Abstract][Full Text] [Related]
50. Notch1 promotes the pericyte-myofibroblast transition in idiopathic pulmonary fibrosis through the PDGFR/ROCK1 signal pathway.
Wang YC; Chen Q; Luo JM; Nie J; Meng QH; Shuai W; Xie H; Xia JM; Wang H
Exp Mol Med; 2019 Mar; 51(3):1-11. PubMed ID: 30902967
[TBL] [Abstract][Full Text] [Related]
51. The IκB kinase inhibitor ACHP strongly attenuates TGFβ1-induced myofibroblast formation and collagen synthesis.
Mia MM; Bank RA
J Cell Mol Med; 2015 Dec; 19(12):2780-92. PubMed ID: 26337045
[TBL] [Abstract][Full Text] [Related]
52. Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.
Tsubouchi K; Araya J; Yoshida M; Sakamoto T; Koumura T; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Hashimoto M; Wakui H; Numata T; Kaneko Y; Mori S; Asano H; Matsudaira H; Ohtsuka T; Nakayama K; Nakanishi Y; Imai H; Kuwano K
J Immunol; 2019 Oct; 203(8):2076-2087. PubMed ID: 31534007
[TBL] [Abstract][Full Text] [Related]
53. Cysteine-rich protein 1 is regulated by transforming growth factor-β1 and expressed in lung fibrosis.
Järvinen PM; Myllärniemi M; Liu H; Moore HM; Leppäranta O; Salmenkivi K; Koli K; Latonen L; Band AM; Laiho M
J Cell Physiol; 2012 Jun; 227(6):2605-12. PubMed ID: 21882188
[TBL] [Abstract][Full Text] [Related]
54. Regulation of TGF-β storage and activation in the human idiopathic pulmonary fibrosis lung.
Leppäranta O; Sens C; Salmenkivi K; Kinnula VL; Keski-Oja J; Myllärniemi M; Koli K
Cell Tissue Res; 2012 Jun; 348(3):491-503. PubMed ID: 22434388
[TBL] [Abstract][Full Text] [Related]
55. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
56. Sequential analysis of myofibroblast differentiation and transforming growth factor-β1/Smad pathway activation in murine pulmonary fibrosis.
Usuki J; Matsuda K; Azuma A; Kudoh S; Gemma A
J Nippon Med Sch; 2012; 79(1):46-59. PubMed ID: 22398790
[TBL] [Abstract][Full Text] [Related]
57. Involvement of PARK2-Mediated Mitophagy in Idiopathic Pulmonary Fibrosis Pathogenesis.
Kobayashi K; Araya J; Minagawa S; Hara H; Saito N; Kadota T; Sato N; Yoshida M; Tsubouchi K; Kurita Y; Ito S; Fujita Y; Takasaka N; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Kojima J; Shimizu K; Numata T; Kawaishi M; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Kuwano K
J Immunol; 2016 Jul; 197(2):504-16. PubMed ID: 27279371
[TBL] [Abstract][Full Text] [Related]
58. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
[TBL] [Abstract][Full Text] [Related]
59. Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis.
El Agha E; Moiseenko A; Kheirollahi V; De Langhe S; Crnkovic S; Kwapiszewska G; Szibor M; Kosanovic D; Schwind F; Schermuly RT; Henneke I; MacKenzie B; Quantius J; Herold S; Ntokou A; Ahlbrecht K; Braun T; Morty RE; Günther A; Seeger W; Bellusci S
Cell Stem Cell; 2017 Feb; 20(2):261-273.e3. PubMed ID: 27867035
[TBL] [Abstract][Full Text] [Related]
60. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.
MacKenzie B; Korfei M; Henneke I; Sibinska Z; Tian X; Hezel S; Dilai S; Wasnick R; Schneider B; Wilhelm J; El Agha E; Klepetko W; Seeger W; Schermuly R; Günther A; Bellusci S
Respir Res; 2015 Jul; 16(1):83. PubMed ID: 26138239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
